AI assistant
BIO-TECHNE Corp — Director's Dealing 2020
Aug 11, 2020
30718_dirs_2020-08-11_eb06e26b-25a8-4726-82a0-573064861df1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-08-09
Reporting Person: Eansor Norman David (President-Protein Sciences)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-09 | Common Stock | M | 2174 | — | Acquired | 2174 | Direct |
| 2020-08-09 | Common Stock | F | 856 | $265.76 | Disposed | 1318 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-09 | Restricted Stock Units | $ | M | 2174 | Disposed | Common Stock (2174) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (14114) | 14114 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (18819) | 18819 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (11982) | 11982 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (15976) | 15976 | Direct |
| Restricted Stock Units | $ | Common Stock (2537) | 2537 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (13550) | 13550 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (18066) | 18066 | Direct |
| Restricted Stock Units | $ | Common Stock (3151) | 3151 | Direct | |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (15948) | 15948 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (21265) | 21265 | Direct |
| Restricted Stock Units | $ | Common Stock (2575) | 2575 | Direct | |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (11488) | 11488 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (15318) | 15318 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (24975) | 24975 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (24975.0) | 24975.0 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: On 8/9/2020, the Board of Directors certified vesting of 2,174 performance RSUs.
F3: Fully exercisable.
F4: Options to purchase 4,705 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 4,704 shares vest on 8/18/2020.
F5: Options to purchase 3,994 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
F6: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 4,517 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 4,516 shares vest on each of 8/8/2021 and 8/8/2022.
F8: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 5,317 shares vest on 8/7/2020 and options to purchase 5,316 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
F10: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11: Options to purchase 3,830 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 3,829 shares vest on each of 8/5/2023 and 8/5/2024.
F12: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021
F13: Options to purchase 8,325 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.